![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/355 | |
A61P 3/00 | |||
A61P 25/28 |
(11) | Number of the document | 2471530 |
(13) | Kind of document | T |
(96) | European patent application number | 12162555.2 |
Date of filing the European patent application | 2006-06-01 | |
(97) | Date of publication of the European application | 2012-07-04 |
(45) | Date of publication and mention of the grant of the patent | 2017-01-11 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
686826 P | 2005-06-01 | US | |
701815 P | 2005-07-21 | US | |
776028 P | 2006-02-22 | US |
(72) |
Miller, Guy M.,, US
Hecht, Sidney M.,, US
|
(73) |
Edison Pharmaceuticals, Inc.,
350 North Bernardo Avenue, Mountain View, CA 94043,
US
|
(54) | REDOX-ACTIVE THERAPEUTICS FOR TREATMENT OF MITOCHONDRIAL DISEASES AND OTHER CONDITIONS AND MODULATION OF ENERGY BIOMARKERS |
REDOX-ACTIVE THERAPEUTICS FOR TREATMENT OF MITOCHONDRIAL DISEASES AND OTHER CONDITIONS AND MODULATION OF ENERGY BIOMARKERS |